Table 2.
Variables in the final model for tumor growth pattern as a binary outcome variable (infiltrative vs. expansile-intermediate) |
Multivariate OR (95% CI) |
P value |
---|---|---|
MSI-high (vs. MSI-low/MSS) | 0.15 (0.07-0.34) | <0.0001 |
Peritumoral lymphocytic reaction (present vs. absent) | 0.36 (0.24-0.54) | <0.0001 |
BRAF mutation (vs. wild-type) | 2.89 (1.68-4.98) | 0.0001 |
Poor differentiation (vs. well-moderate) | 2.27 (1.31-3.92) | 0.0035 |
LINE-1 hypomethylation (for a 30% decrease) | 0.55 (0.30-1.00) | 0.049 |
Year of diagnosis (for a 10-year increase) | 0.75 (0.55-1.02) | 0.065 |
KRAS mutation (vs. wild-type) | 1.31 (0.90-1.92) | 0.16 |
Multivariate logistic regression analysis assessing the relationship with infiltrative growth pattern (as an outcome variable) initially included age, sex, year of diagnosis, body mass index, tumor location, family history of colorectal cancer, microsatellite instability, CpG island methylator phenotype, LINE-1 methylation, KRAS, BRAF, PIK3CA, tumor differentiation, mucinous component, signet ring cell component, and peritumoral lymphocytic reaction. A backward elimination with a threshold of p=0.20 was used to select variables in the final models. Because of multiple hypothesis testing, a p value for significance was adjusted by Bonferroni correction to p=0.0029.
CI, confidence interval; MSI, microsatellite instability; MSS, microsatellite stable; OR, odds ratio.